Doseology Sciences, Inc. ( (TSE:MOOD) ) has issued an update.
Doseology Sciences Inc. announced a debt settlement agreement involving the issuance of 236,364 common shares at a price of $0.165 per share to settle $39,000 in debt for past consulting services. This strategic move is likely to impact the company’s financial operations by reducing debt through equity issuance, potentially strengthening its position within the functional mushroom supplement industry.
More about Doseology Sciences, Inc.
Doseology Sciences Inc. is a company specializing in premium functional mushroom supplements designed for targeted health results. Their products are formulated by health experts and are based on scientific research, utilizing one hundred percent mushroom fruiting bodies for maximum purity and potency. The company is focused on optimizing well-being through the power of fungi and offers a liquid format for faster absorption.
YTD Price Performance: 10.0%
Average Trading Volume: 7,027
Technical Sentiment Consensus Rating: Buy
Current Market Cap: C$851.6K
For an in-depth examination of MOOD stock, go to TipRanks’ Stock Analysis page.